Clinical Trial Update: Effect of Inhaled Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (18 to 65 y) (BY9010/M1-129) [Phase 3]

View source ↗

Summary

A Phase 3 randomized study comparing inhaled ciclesonide to fluticasone propionate in adults with mild to moderate asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Alvesco (ciclesonide)
• Flovent (fluticasone propionate)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED